🌿 Environment Sep 1, 2026 · Jonathan Gardner

Mid-cap biotechs join Trump’s latest round of drug pricing deals

Healthcare Dive
Healthcare industry news
View Channel →
Mid-cap biotechs join Trump’s latest round of drug pricing deals
Source ↗ 👁 4 💬 0
Focused on Medicaid, the new pacts now involve more than just large pharmaceutical companies.

Comments (0)

Sign in to join the discussion

More Like This

Plants' response to rising CO₂ could put the brakes on dryland expansion
Earth News - Earth Science News, Earth Science, Climate Change · Sep 8, 2026
A mysterious kidney disease has arrived in Texas
EHN · Sep 8, 2026
The fix for EV battery waste isn’t recycling. It’s geography
EHN · Sep 8, 2026
The making of an AI data center warrior
EHN · Sep 8, 2026
Why does Southeast Asia keep breathing the same haze — and can ASEAN do more to stop it?
EHN · Sep 8, 2026
Federal inspectors say Palisades failed to follow regulations on radiation exposure
EHN · Sep 8, 2026